Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic study in young patients with chronic kidney disease stage G5 from unknown etiology. The GENSEN study design Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN

  • Blasco Pelicano, Miquel|||0000-0003-0789-7992
  • Quiroga, Borja|||0000-0001-5730-1929
  • García-Aznar, José M.
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Ortiz, Alberto|||0000-0002-9805-9523
  • de Sequera, Patricia|||0000-0001-7705-9228
Introduction: Chronic kidney disease (CKD) of unknown etiology is one of the main causes of renal replacement therapy in our environment. Previous studies in other territories suggest that hereditary diseases could be one of the potential causes of this pathology, especially in younger patients. The GENSEN study will evaluate the presence of pathogenic genetic variants in subjects who have developed CKD category G5 before the age of 46, of unknown etiology. Methods: Observational, prospective and multicenter study, which evaluates the diagnostic usefulness of massive high-throughput sequencing (HTS) directed at a set of genes, in identifying the cause of CKD. Patients from all over Spain will be included, from whom a blood or saliva sample will be extracted, subsequently analyzing a panel of 529 genes associated with hereditary kidney disease. This publication communicates the study protocol and design. Conclusion: The GENSEN study will allow to evaluate the diagnostic performance of a gene panel study in young subjects from our environment with the development of category G5 CKD without a clear cause. An etiological diagnosis would offer potential benefits for patients and relatives (targeted therapies, clinical trials, detection of extrarenal manifestations, evaluation of relatives for living kidney donation, estimation of the risk of recurrence in the kidney graft, genetic counseling, among others) and would allow genetic study to be brought closer to nephrology in our country.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN

  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Lipska-Ziętkiewicz, Beata S.|||0000-0002-4169-9685
  • Acke, Frederic|||0000-0001-6312-4260
  • Antignac, Corinne|||0000-0002-9934-4940
  • Becker, Jan Ulrich|||0000-0003-2929-8085
  • Cornec-Le Gall, Emilie|||0000-0003-1958-4459
  • van Eerde, Albertien M.|||0000-0001-5953-5956
  • Feltgen, Nicolas|||0000-0002-6857-3003
  • Ferrari, Rossella
  • Gale, Daniel|||0000-0002-9170-1579
  • Gear, Susie
  • Gross, Oliver|||0000-0002-8390-8852
  • Haeberle, Stefanie
  • Heidet, Laurence|||0000-0002-1362-5515
  • Lennon, Rachel|||0000-0001-6400-0227
  • Massella, Laura|||0000-0001-5796-3965
  • Pfau, Kristina|||0000-0002-3642-3502
  • Venegas, María del Prado|||0000-0001-9048-4501
  • Topaloglu, Rezan|||0000-0002-6423-0927
  • Wlodkowski, Tanja
  • Zealey, Heidi
Glomerular nephropathy resulting from the genetic defects in COL4A3/4/5 genes including the classical Alport syndrome is the second most common hereditary kidney disease characterized by persistent haematuria progressing to the need for kidney replacement therapy, frequently associated with sensorineural deafness, and occasionally with ocular anomalies. Diagnosis and management of COL4A3/4/5 glomerulopathy is a great challenge due to its phenotypic heterogeneity, multiple modes of inheritance, variable expressivity, and disease penetrance of individual variants as well as imperfect prognostic and progression factors and scarce and limited clinical trials, especially in children. As a joint initiative of the European Rare Kidney disease reference Network (ERKNet), European Renal Association (ERA Genes&Kidney), and European Society for Paediatric Nephrology (ESPN) Inherited renal disorders working group, a team of experts including adult and paediatric nephrologists, kidney geneticists, audiologists, ophthalmologists, and a kidney pathologist were selected to perform a systematic literature review on 21 clinically relevant PICO (Patient or Population covered, Intervention, Comparator, Outcome) questions. The experts formulated recommendations and formally graded them at a consensus meeting with input from patient representatives and a voting panel of nephrologists representing all regions of the world. Genetic diagnostics comprising joint analysis of COL4A3/4/5 genes is already the key diagnostic test during the initial evaluation of an individual presenting with persistent haematuria, proteinuria, kidney failure of unknown origin, focal segmental sclerosis of unknown origin, and possibly cystic kidney disease. Early renin-angiotensin system blockade is the standard of care therapy; sodium-glucose cotransporter-2 inhibitors may be added in adults with proteinuria and chronic kidney disease. Relatives with heterozygous COL4A3/4/5 variants should only be considered as the last possible resource for living kidney donation. This guideline provides guidance for the diagnosis and management of individuals with pathogenic variants in COL4A3/4/5 genes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants

  • Furlano, Monica|||0000-0003-1025-3901
  • Pilco-Teran, Melissa|||0000-0002-1311-0896
  • Pybus, Marc|||0000-0002-6195-5738
  • Martínez, Víctor
  • Aza-Carmona, Miriam|||0000-0003-4448-9541
  • Rius Peris, Asunción
  • Pérez-Gómez, Maria Vanessa|||0000-0003-4558-5236
  • Berná, Gerson
  • Mazon, Jaime
  • Hernández Mancera, Jonathan|||0000-0002-2267-7536
  • Fayos de Arizón, Leonor|||0000-0002-9277-645X
  • Viera, Elizabeth|||0000-0002-3548-7061
  • Gich, Ignasi|||0000-0003-3975-6588
  • Pérez, Hugo Vergara
  • Gomá-Garcés, Elena
  • Albero Dolon, José Luis
  • Ars, Elisabet|||0000-0002-4118-4358
  • Torra Balcells, Roser|||0000-0001-8714-2332
Clinical variability among individuals with heterozygous pathogenic/likely pathogenic (P/LP) variants in the COL4A3 / COL4A4 genes (also called autosomal dominant Alport syndrome or COL4A3/COL4A4 -related disorder) is huge; many individuals are asymptomatic or show microhematuria, while others may develop proteinuria and chronic kidney disease (CKD). The prevalence of simple kidney cysts (KC) in the general population varies according to age, and patients with advanced CKD are prone to have them. A possible association between heterozygous COL4A3, COL4A4 and COL4A5 P/LP variants and KC has been described in small cohorts. The presence of KC in a multicenter cohort of individuals with heterozygous P/LP variants in the COL4A3 / COL4A4 genes is assessed in this study. We evaluated the presence of KC by ultrasound in 157 individuals with P/LP variants in COL4A3 (40.7%) or COL4A4 (53.5%) without kidney replacement therapy. The association between presence of KC and age, proteinuria, estimated glomerular filtration rate (eGFR) and causative gene was analyzed. Prevalence of KC was compared with historical case series in the general population. Half of the individuals with P/LP variants in COL4A3 / COL4A4 showed KC, which is a significantly higher percentage than in the general population. Only 3.8% (6/157) had cystic nephromegaly. Age and eGFR showed an association with the presence of KC (P <.001). No association was found between KC and proteinuria, sex or causative gene. Individuals with COL4A3 / COL4A4 P/LP variants are prone to develop KC more frequently than the general population, and their presence is related to age and to eGFR. Neither proteinuria, sex nor the causative gene influences the presence of KC in these individuals. OrderedDict([(u'fig', OrderedDict([(u'@position', u'float'), (u'@id', u'ga1'), (u'label', u'Graphical Abstract'), (u'graphic', OrderedDict([(u'@xlink:href', u'gfae031fig1g'), (u'@position', u'float')]))]))]).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Autosomal dominant polycystic kidney disease in young adults

  • Martínez, Víctor
  • Furlano, Monica|||0000-0003-1025-3901
  • Sans, Laia
  • Pulido, Lissett
  • García, Rebeca|||0000-0003-0649-2766
  • Pérez-Gómez, Maria Vanessa|||0000-0003-4558-5236
  • Sánchez-Rodríguez, Jinny
  • Blasco Pelicano, Miquel|||0000-0003-0789-7992
  • Castro-Alonso, Cristina|||0000-0002-8363-1953
  • Fernández-Fresnedo, Gema
  • Robles, Nicolás Roberto|||0000-0003-4984-6691
  • Valenzuela, María Pau
  • Naranjo, Javier|||0000-0002-7004-6122
  • Martín Alemany, Nàdia|||0000-0002-4370-7562
  • Pilco-Teran, Melissa|||0000-0002-1311-0896
  • Agraz Pamplona, Irene|||0000-0002-4223-6834
  • González-Rodríguez, Juan David|||0000-0002-8863-2007
  • Panizo, Nayara|||0000-0002-1329-2976
  • Fraga Rodriguez, Gloria Maria|||0000-0002-7682-1396
  • Fernández, Loreto
  • López, María Teresa
  • Dall'Anese, Cecilia
  • Ortiz, Alberto|||0000-0002-9805-9523
  • Torra Balcells, Roser|||0000-0001-8714-2332
The clinical manifestations of autosomal dominant polycystic kidney disease (ADPKD) usually appear in adulthood, however pediatric series report a high morbidity. The objective of the study was to analyze the clinical characteristics of ADPKD in young adults. Family history, hypertension, albuminuria, estimated glomerular filtration rate (eGFR) and imaging tests were examined in 346 young adults (18-30 years old) out of 2521 patients in the Spanish ADPKD registry (REPQRAD). A literature review searched for reports on hypertension in series with more than 50 young (age <30 years) ADPKD patients. The mean age of this young adult cohort was 25.24 (SD 3.72) years. The mean age at diagnosis of hypertension was 21.15 (SD 4.62) years, while in the overall REPQRAD population was aged 37.6 years. The prevalence of hypertension was 28.03% and increased with age (18-24 years, 16.8%; 25-30 years, 36.8%). Although prevalence was lower in women than in men, the age at onset of hypertension (21 years) was similar in both sexes. Mean eGFR was 108 (SD 21) mL/min/1.73 m 2, 38.0% had liver cysts and 3.45% of those studied had intracranial aneurysms. In multivariate analyses, hematuria episodes and kidney length were independent predictors of hypertension (area under the curve 0.75). The prevalence of hypertension in 22 pediatric cohorts was 20%-40%, but no literature reports on hypertension in young ADPKD adults were found. Young adults present non-negligible ADPKD-related morbidity. This supports the need for a thorough assessment of young adults at risk of ADPKD that allows early diagnosis and treatment of hypertension.